Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS4330

Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5

Analysis of ileum neuroendocrine tumor (NET) cell line CNDT2.5 treated with octreotide for up to 16 months. Somatostain analog octreotide is used to treat NET patients. Results provided insight into molecular basis of successful octreotide therapy or the development of drug resistance in NETs.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 agent, 5 cell line, 3 time sets
Platform:
GPL6244
Series:
GSE24358
8 Samples
Download data: CEL, CHP

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center